Multiple drug intolerance syndrome
Reactions reported to several unrelated drug classes · Allergy / Immunology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Multiple drug intolerance syndrome is adverse reactions to three or more chemically unrelated drugs without a consistent immunological mechanism, frequently involving subjective symptoms and a background of anxiety. Careful allergy delabelling prevents escalating avoidance that compromises future treatment.
Red flags
- Objective signs (urticaria, angioedema, hypotension) with any drug
- Raised baseline tryptase (mast cell disorder)
- Reaction to a drug essential for a current serious illness
- Escalating avoidance preventing necessary treatment
- Features of systemic reaction during challenge
Assessment
Differential diagnosis
- True multiple drug allergy (immunologically confirmed)
- Multiple drug intolerance syndrome (non-immune)
- Underlying mast cell disorder
- Somatic symptom / anxiety disorder
- Chronic spontaneous urticaria with drug-attributed flares
Investigations
- Structured history of each reported reaction, timing and features
- Review documentation for objective versus subjective reactions
- Baseline mast cell tryptase to exclude mastocytosis
- Targeted skin testing / specific IgE for plausible IgE-mediated culprits
- Supervised drug provocation (challenge) testing where safe to delabel
Management
- Take a detailed history separating objective reactions from subjective intolerances
- Identify any reactions with genuine allergic features for formal testing
- Exclude an underlying mast cell disorder with baseline tryptase
- Reassure and avoid reinforcing unnecessary labels
- Perform supervised graded drug provocation to delabel safe drugs
- Build a documented list of tolerated medications for future use
- Address coexisting anxiety and provide clear written guidance
- Refer complex cases to a specialist drug allergy service
Drugs & doses
Cetirizine — 10 mg orally for symptomatic relief during assessment
Adrenaline IM — 500 mcg (0.5 mL 1:1000) available during provocation testing
Chlorphenamine — 10 mg IV/IM for reactions during challenge
Hydrocortisone — 200 mg IV for severe reactions during challenge
Disposition
Outpatient specialist drug allergy assessment with provocation testing; no admission unless a reaction occurs during a monitored challenge.
Complications & pitfalls
- Avoidance of safe, effective first-line drugs
- Use of inferior or more toxic alternatives
- Missed true allergy or mast cell disorder
- Reinforcement of health anxiety
- Delay to essential treatment
Exam pearls
- Most reactions in this syndrome are subjective and non-immune — careful delabelling is key
- Always exclude an underlying mast cell disorder with baseline tryptase
- Supervised provocation testing is the most reliable way to restore safe options
- Document a positive list of tolerated drugs, not just a list of avoidances
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.